Trials / Completed
CompletedNCT05687825
Risk Factors for Clinically Relevant Postoperative Pancreatic Fistula
Operative Risk Factors for Clinically Relevant Postoperative Pancreatic Fistula After Pancreaticoduodenectomy: A Prospective Multicenter Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 107 (actual)
- Sponsor
- South Valley University · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
For periampullary and pancreatic head disorders, pancreaticoduodenectomy (PD) is the standard treatment. However, PD is technically demanding and has high morbidity and mortality rates. The most significant and life-threatening complication of PD is postoperative pancreatic fistula (POPF), with reported rates of 5 to 70% for total POPF and 10 to 45% for clinically relevant (CR-POPF). Operative risk variables for CR-POPF after PD were investigated in this study.
Detailed description
For periampullary and pancreatic head disorders, pancreaticoduodenectomy (PD) is the standard treatment. However, PD is technically demanding and has high morbidity and mortality rates. The most significant and life-threatening complication of PD is postoperative pancreatic fistula (POPF), with reported rates of 5 to 70% for total POPF and 10 to 45% for clinically relevant (CR-POPF). Operative risk variables for CR-POPF after PD were investigated in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | pancreaticoduodenectomy procedure | Pancreaticoduodenectomy operation |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2022-07-30
- Completion
- 2022-07-30
- First posted
- 2023-01-18
- Last updated
- 2023-07-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05687825. Inclusion in this directory is not an endorsement.